Overview
Mohamad Sabbah practices practicing medicine in Paris, France.
His clinical expertise encompasses B-Cell Lymphoma, Non-Hodgkin Lymphoma, Bone Graft, and Bone Marrow Transplant.
He is actively involved in clinical research, co-authoring 8 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Mohamad Sabbah
Is Mohamad Sabbah a top-rated expert for Bone Graft?
MediFind is an objective health platform that identifies experts based on real-world data. Mohamad Sabbah is classified as an Experienced expert for Bone Graft, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Mohamad Sabbah participate in research or clinical trials?
Yes. Mohamad Sabbah has published 8 articles and abstracts on conditions like Bone Graft. You can view a list of Mohamad Sabbah's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- B-Cell LymphomaMr. Sabbah isExperienced. Learn about B-Cell Lymphoma.
- Bone GraftMr. Sabbah isExperienced. Learn about Bone Graft.
- Bone Marrow TransplantMr. Sabbah isExperienced. Learn about Bone Marrow Transplant.
- Non-Hodgkin LymphomaMr. Sabbah isExperienced. Learn about Non-Hodgkin Lymphoma.